Variant report

Variant	esv3357658
Chromosome Location	chr4:15940054-15944352
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:51)
CpG islands
(count:244)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:51 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr4:15939879-15940190	Hela-S3	cervix:	n/a	n/a
2	CTCF	chr4:15940160-15940310	SAEC	small airway:	n/a	n/a
3	CTCF	chr4:15940060-15940210	HEEpiC	esophagus:	n/a	n/a
4	CTCF	chr4:15940140-15940290	HMEC	breast:	n/a	n/a
5	CTCF	chr4:15942255-15942314	GM19239	blood:	n/a	n/a
6	EP300	chr4:15939569-15940619	ECC-1	luminal epithelium:	n/a	chr4:15940557-15940571
7	FOS	chr4:15939889-15940075	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr4:15939984-15940184	MCF10A-Er-Src	breast:	n/a	n/a
9	FOS	chr4:15939889-15940204	MCF10A-Er-Src	breast:	n/a	n/a
10	FOS	chr4:15939804-15940200	MCF10A-Er-Src	breast:	n/a	n/a
11	MAFF	chr4:15944025-15944267	K562	blood:	n/a	chr4:15944094-15944112
12	MAFF	chr4:15943929-15944286	HepG2	liver:	n/a	chr4:15944094-15944112
13	MAFK	chr4:15943935-15944282	IMR90	lung:	n/a	chr4:15944096-15944111
14	MAFK	chr4:15944019-15944267	K562	blood:	n/a	chr4:15944096-15944111
15	MAFK	chr4:15943928-15944280	HepG2	liver:	n/a	chr4:15944096-15944111
16	MAFK	chr4:15943945-15944268	HepG2	liver:	n/a	chr4:15944096-15944111
17	MAX	chr4:15939699-15940347	ECC-1	luminal epithelium:	n/a	n/a
18	MAX	chr4:15939610-15940442	HCT-116	colon:	n/a	n/a
19	MAX	chr4:15939635-15940382	ECC-1	luminal epithelium:	n/a	n/a
20	MAZ	chr4:15939880-15940096	Hela-S3	cervix:	n/a	n/a
21	MXI1	chr4:15939916-15940187	Hela-S3	cervix:	n/a	n/a
22	MYC	chr4:15939798-15940218	MCF10A-Er-Src	breast:	n/a	n/a
23	MYC	chr4:15939855-15940209	MCF10A-Er-Src	breast:	n/a	n/a
24	MYC	chr4:15942265-15942319	MCF-7	breast:	n/a	n/a
25	MYC	chr4:15942322-15942355	MCF-7	breast:	n/a	n/a
26	NFIC	chr4:15939667-15940481	ECC-1	luminal epithelium:	n/a	n/a
27	NFIC	chr4:15939701-15940436	ECC-1	luminal epithelium:	n/a	n/a
28	PBX3	chr4:15942069-15942240	GM12878	blood:	n/a	n/a
29	POLR2A	chr4:15943278-15943348	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr4:15939712-15940305	ECC-1	luminal epithelium:	n/a	n/a
31	POLR2A	chr4:15934291-15944634	MCF10A-Er-Src	breast:	n/a	n/a
32	POLR2A	chr4:15939052-15940305	MCF10A-Er-Src	breast:	n/a	n/a
33	POLR2A	chr4:15939809-15940148	HCT-116	colon:	n/a	n/a
34	POLR2A	chr4:15939734-15940196	HCT-116	colon:	n/a	n/a
35	POLR2A	chr4:15940786-15940870	MCF10A-Er-Src	breast:	n/a	n/a
36	POLR2A	chr4:15941308-15941730	MCF10A-Er-Src	breast:	n/a	n/a
37	PRDM1	chr4:15939918-15940282	Hela-S3	cervix:	n/a	chr4:15940080-15940095 chr4:15940085-15940094
38	SMC3	chr4:15939735-15940221	Hela-S3	cervix:	n/a	chr4:15939769-15939779
39	SP1	chr4:15939763-15940429	HCT-116	colon:	n/a	chr4:15940054-15940064 chr4:15940054-15940064
40	STAT3	chr4:15939966-15940245	MCF10A-Er-Src	breast:	n/a	chr4:15940080-15940091
41	STAT3	chr4:15939898-15940153	MCF10A-Er-Src	breast:	n/a	chr4:15940080-15940091
42	STAT3	chr4:15940007-15940200	MCF10A-Er-Src	breast:	n/a	chr4:15940080-15940091
43	STAT3	chr4:15943401-15943587	MCF10A-Er-Src	breast:	n/a	n/a
44	STAT3	chr4:15939900-15940201	MCF10A-Er-Src	breast:	n/a	chr4:15940080-15940091
45	TBP	chr4:15939877-15940097	H1-hESC	embryonic stem cell:	n/a	n/a
46	TCF12	chr4:15939531-15940459	ECC-1	luminal epithelium:	n/a	n/a
47	TCF12	chr4:15939620-15940348	ECC-1	luminal epithelium:	n/a	n/a
48	TCF7L2	chr4:15939795-15940203	Hela-S3	cervix:	n/a	n/a
49	TEAD4	chr4:15939565-15940334	ECC-1	luminal epithelium:	n/a	n/a
50	USF2	chr4:15939890-15940068	Hela-S3	cervix:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:15940541-15940591	GM19239	blood:	n/a
2	chr4:15940058-15940108	ovcar-3	ovarian:	n/a
3	chr4:15940058-15940108	NT2-D1	testis:	n/a
4	chr4:15940058-15940108	HPAEpiC	pulmonary alveolar:	n/a
5	chr4:15940033-15940083	HRCEpiC	kidney:	n/a
6	chr4:15940033-15940083	MCF-7	breast:	n/a
7	chr4:15940033-15940083	ECC-1	luminal epithelium:	n/a
8	chr4:15940033-15940083	SK-N-MC	brain:	n/a
9	chr4:15940897-15940947	PANC-1	pancreas:	n/a
10	chr4:15940058-15940108	NB4	blood:	n/a
11	chr4:15940058-15940108	SKMC	muscle:	n/a
12	chr4:15940033-15940083	SK-N-SH_RA	brain:	n/a
13	chr4:15940541-15940591	H1-hESC	embryonic stem cell:	embryo
14	chr4:15940058-15940108	T-47D	breast:	n/a
15	chr4:15940897-15940947	AG09319	gingival:	n/a
16	chr4:15940897-15940947	HRPEpiC	eye:	n/a
17	chr4:15940033-15940083	HIPEpiC	eye:	n/a
18	chr4:15940897-15940947	K562	blood:	n/a
19	chr4:15940541-15940591	HepG2	liver:	n/a
20	chr4:15940033-15940083	HEEpiC	esophagus:	n/a
21	chr4:15940058-15940108	LNCaP	prostate:	n/a
22	chr4:15940897-15940947	GM19239	blood:	n/a
23	chr4:15940541-15940591	NT2-D1	testis:	n/a
24	chr4:15940541-15940591	RPTEC	kidney:	n/a
25	chr4:15940897-15940947	AG04449	skin:	fetal
26	chr4:15940541-15940591	PANC-1	pancreas:	n/a
27	chr4:15940541-15940591	AG09309	skin:	n/a
28	chr4:15940058-15940108	HAEpiC	amniotic membrane:	n/a
29	chr4:15940058-15940108	HEK293	kidney:	embryo
30	chr4:15940058-15940108	K562	blood:	n/a
31	chr4:15940897-15940947	HRCEpiC	kidney:	n/a
32	chr4:15940541-15940591	HEEpiC	esophagus:	n/a
33	chr4:15940033-15940083	AoSMC	blood vessel:	n/a
34	chr4:15940897-15940947	HRE	kidney:	n/a
35	chr4:15940897-15940947	Jurkat	blood:	n/a
36	chr4:15940033-15940083	IMR90	lung:	fetal
37	chr4:15940033-15940083	GM12891	blood:	n/a
38	chr4:15940058-15940108	HL-60	blood:	n/a
39	chr4:15940541-15940591	HPAEpiC	pulmonary alveolar:	n/a
40	chr4:15940058-15940108	GM12878	blood:	n/a
41	chr4:15940541-15940591	NB4	blood:	n/a
42	chr4:15940058-15940108	HIPEpiC	eye:	n/a
43	chr4:15940897-15940947	HUVEC	blood vessel:	n/a
44	chr4:15940033-15940083	ovcar-3	ovarian:	n/a
45	chr4:15940541-15940591	SK-N-SH_RA	brain:	n/a
46	chr4:15940897-15940947	GM12891	blood:	n/a
47	chr4:15940541-15940591	Hela-S3	cervix:	n/a
48	chr4:15940897-15940947	IMR90	lung:	fetal
49	chr4:15940033-15940083	NHDF-neo	bronchial:	n/a
50	chr4:15940541-15940591	SAEC	small airway:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:15941251..15943362-chr4:15944391..15946203,2	K562	blood:

No data

Variant related genes	Relation type
FGFBP1	TF binding region
FGFBP1	CpG island

Extended variants
information (count: 188 )
Associated
traits (count: 48 )

Variant overlapped rSNPs/rCNVs (count:188 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs561302385	chr4:15940055-15940056	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs531673545	chr4:15940067-15940068	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs530350356	chr4:15940075-15940076	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs111648408	chr4:15940091-15940092	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs563956043	chr4:15940125-15940126	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs532800877	chr4:15940127-15940128	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs571641219	chr4:15940141-15940142	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs78226774	chr4:15940142-15940143	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs565789288	chr4:15940157-15940158	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs73801537	chr4:15940168-15940169	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs547898040	chr4:15940188-15940189	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs547829927	chr4:15940201-15940202	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs568074020	chr4:15940203-15940204	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs2531174	chr4:15940205-15940206	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs143703364	chr4:15940214-15940215	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs12503796	chr4:15940231-15940232	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs570413425	chr4:15940247-15940248	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs148125333	chr4:15940281-15940282	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs61635820	chr4:15940294-15940295	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs572224368	chr4:15940339-15940340	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs541488564	chr4:15940354-15940355	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs115600091	chr4:15940386-15940387	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs190519573	chr4:15940399-15940400	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs34030911	chr4:15940444-15940445	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs543449846	chr4:15940484-15940485	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs563974233	chr4:15940506-15940507	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs532813021	chr4:15940529-15940530	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs556373702	chr4:15940542-15940543	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs569930569	chr4:15940550-15940551	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs538915082	chr4:15940551-15940552	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs528653597	chr4:15940552-15940553	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs548298189	chr4:15940583-15940584	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs561616409	chr4:15940590-15940591	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs370595981	chr4:15940595-15940596	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs544625102	chr4:15940637-15940638	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs181888030	chr4:15940664-15940665	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs562533602	chr4:15940686-15940687	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs550116893	chr4:15940735-15940736	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs570425673	chr4:15940740-15940741	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs558824951	chr4:15940799-15940800	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs577523203	chr4:15940878-15940879	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs140924190	chr4:15940898-15940899	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs533189449	chr4:15940905-15940906	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs185700630	chr4:15940952-15940953	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs146434411	chr4:15941058-15941059	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs35715258	chr4:15941068-15941069	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs139051565	chr4:15941136-15941137	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs190491891	chr4:15941161-15941162	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs529617300	chr4:15941174-15941175	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs574793517	chr4:15941273-15941274	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:48)

Disease	PMID	Source
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:15938200-15940200	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr4:15938200-15941600	Weak transcription	Right Atrium	heart
3	chr4:15939200-15940400	Enhancers	Stomach Mucosa	stomach
4	chr4:15939600-15940200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr4:15939600-15940200	Enhancers	Placenta Amnion	Placenta Amnion
6	chr4:15939600-15940400	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr4:15939600-15940400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr4:15939600-15940400	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr4:15939600-15940600	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr4:15939800-15940200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
11	chr4:15939800-15940200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr4:15939800-15940200	Enhancers	H1 Cell Line	embryonic stem cell
13	chr4:15939800-15940200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr4:15939800-15940200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr4:15939800-15940200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr4:15939800-15940200	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
17	chr4:15939800-15940200	Enhancers	Lung	lung
18	chr4:15939800-15940200	Enhancers	Pancreas	Pancrea
19	chr4:15939800-15940200	Flanking Active TSS	A549	lung
20	chr4:15939800-15940400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr4:15939800-15940400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr4:15939800-15940400	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr4:15939800-15941000	Enhancers	Rectal Mucosa Donor 29	rectum
24	chr4:15939800-15941000	Enhancers	Rectal Mucosa Donor 31	rectum
25	chr4:15940000-15940200	Bivalent Enhancer	Small Intestine	intestine
26	chr4:15940000-15940400	Enhancers	Colonic Mucosa	Colon
27	chr4:15940000-15940400	Enhancers	Fetal Intestine Large	intestine
28	chr4:15940000-15940400	Flanking Active TSS	HMEC	breast
29	chr4:15940000-15940600	Enhancers	Hela-S3	cervix
30	chr4:15940000-15940800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr4:15940000-15941000	Flanking Active TSS	NHEK	skin
32	chr4:15940000-15950600	Weak transcription	Esophagus	oesophagus
33	chr4:15940200-15940400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr4:15940200-15940400	Enhancers	Thymus	Thymus
35	chr4:15940200-15940400	Enhancers	A549	lung
36	chr4:15940200-15940600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr4:15940200-15941000	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr4:15940200-15983600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr4:15940400-15940600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr4:15940400-15941000	Enhancers	HMEC	breast
41	chr4:15940400-15942000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
42	chr4:15940600-15940800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr4:15940600-15941600	Weak transcription	HUES6 Cell Line	embryonic stem cell
44	chr4:15940800-15941000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr4:15940800-15941000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr4:15941000-15942000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr4:15941000-15942200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr4:15941000-15942400	Enhancers	NHEK	skin
49	chr4:15941000-15953400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr4:15941600-15942200	Enhancers	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links